Eligibility Type 2 Diabetes Mellitus NCT00422487

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent | Hypoglycemic Agents Quantity | Thiazolidinediones Excluded | Sulfonylurea Compounds | Glyburide | Glipizide | glimepiride | Meglitinide | Prandin | Starlix | Metformin | Glucophage | alpha-Glucosidase Inhibitors | Acarbose | miglitol | Byetta
Item
type 2 diabetes previously controlled with up to one or two non-tzd hypoglycemic agents including sulfonylureas (e.g., glyburide, glipizide, glimeprimide), meglitinides (e.g., prandin®, starlix®), metformin (e.g., glucophage®), α-glucosidase inhibitors (e.g.,acarbose, miglitol) or byetta®
boolean
C0011860 (UMLS CUI [1])
C0020616 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C1257987 (UMLS CUI [3,1])
C2828389 (UMLS CUI [3,2])
C0038766 (UMLS CUI [4])
C0017628 (UMLS CUI [5])
C0017642 (UMLS CUI [6])
C0061323 (UMLS CUI [7])
C0065880 (UMLS CUI [8])
C0722725 (UMLS CUI [9])
C1323198 (UMLS CUI [10])
C0025598 (UMLS CUI [11])
C0591573 (UMLS CUI [12])
C1299007 (UMLS CUI [13])
C0050393 (UMLS CUI [14])
C0066535 (UMLS CUI [15])
C1636686 (UMLS CUI [16])
Female Sterilization | Postmenopausal state
Item
all female patients must be either surgically sterile or post-menopausal.
boolean
C0015787 (UMLS CUI [1])
C0232970 (UMLS CUI [2])
Gender Male Condoms | Partner Female Childbearing Potential | Childbearing Potential Contraceptive methods
Item
male patients with female partners of childbearing potential must agree to use condoms, or their partner must use a medically acceptable form of contraception.
boolean
C0079399 (UMLS CUI [1,1])
C0009653 (UMLS CUI [1,2])
C0682323 (UMLS CUI [2,1])
C0086287 (UMLS CUI [2,2])
C3831118 (UMLS CUI [2,3])
C3831118 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
Body mass index
Item
bmi 24-44 kg/m2.
boolean
C1305855 (UMLS CUI [1])
Plasma fasting glucose measurement
Item
patients must have a fpg ≤ 200 mg/dl at screening.
boolean
C0583513 (UMLS CUI [1])
Glycosylated hemoglobin A
Item
patients must have hemoglobin a1c ≥ 6.5%, ≤ 10.0% at screening.
boolean
C0019018 (UMLS CUI [1])
ECG normal | Chest X-ray normal
Item
electrocardiogram (ecg) and chest x-ray must be normal, or considered not clinically significant, for participation in this study.
boolean
C0522054 (UMLS CUI [1])
C0239026 (UMLS CUI [2])
Blood Pressure | Hypertensive disease Controlled by Pharmaceutical Preparations
Item
patients must have a blood pressure ≤ 160/90 mm/hg including hypertensive patients controlled with medication.
boolean
C0005823 (UMLS CUI [1])
C0020538 (UMLS CUI [2,1])
C0332298 (UMLS CUI [2,2])
C0013227 (UMLS CUI [2,3])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus, Insulin-Dependent | Diabetes Mellitus Secondary to Pancreatitis | Diabetes Mellitus Secondary to Pancreatectomy
Item
history of type 1 diabetes or diabetes secondary to pancreatitis or pancreatectomy.
boolean
C0011854 (UMLS CUI [1])
C0011849 (UMLS CUI [2,1])
C0175668 (UMLS CUI [2,2])
C0030305 (UMLS CUI [2,3])
C0011849 (UMLS CUI [3,1])
C0175668 (UMLS CUI [3,2])
C0030279 (UMLS CUI [3,3])
Thiazolidinediones | Actos | Avandia
Item
history of tzd use (actos or avandia) within 6 months of screening visit.
boolean
C1257987 (UMLS CUI [1])
C0875954 (UMLS CUI [2])
C0875967 (UMLS CUI [3])
Thiazolidinediones Discontinued Due to Lack of Efficacy
Item
history of tzd discontinuation due to lack of efficacy.
boolean
C1257987 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C0678226 (UMLS CUI [1,3])
C0235828 (UMLS CUI [1,4])
Congestive heart failure Disease length
Item
history of congestive heart failure within last 5 years.
boolean
C0018802 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Lung diseases | Myocardial Infarction | Cerebrovascular accident | Nephrotic Syndrome
Item
history of significant pulmonary disease, myocardial infarction, cerebrovascular accident, or nephrotic syndrome within last 1 year.
boolean
C0024115 (UMLS CUI [1])
C0027051 (UMLS CUI [2])
C0038454 (UMLS CUI [3])
C0027726 (UMLS CUI [4])
Malignant Neoplasms | Basal cell carcinoma Resected Excluded
Item
malignancy within the last 5 years (except resected basal cell carcinoma).
boolean
C0006826 (UMLS CUI [1])
C0007117 (UMLS CUI [2,1])
C1521996 (UMLS CUI [2,2])
C2828389 (UMLS CUI [2,3])
Communicable Diseases
Item
ongoing active infection.
boolean
C0009450 (UMLS CUI [1])
Antilipemic agent Changed
Item
change in treatment with lipid-lowering agent within 7 days of screening visit.
boolean
C0086440 (UMLS CUI [1,1])
C0392747 (UMLS CUI [1,2])
Anticoagulant therapy Requirement Expected | Aspirin Low Dose Excluded | Plavix Dosage Excluded
Item
current or expected requirement for anticoagulant therapy [except for low-dose aspirin ≤ 325 mg/d or plavix® ≤ 75 mg/d].
boolean
C0150457 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C1517001 (UMLS CUI [1,3])
C2608320 (UMLS CUI [2,1])
C2828389 (UMLS CUI [2,2])
C0633084 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C2828389 (UMLS CUI [3,3])
Phenytoin Expected
Item
current or expected treatment with phenytoin for the duration of the study.
boolean
C0031507 (UMLS CUI [1,1])
C1517001 (UMLS CUI [1,2])
allergy to nonsteroidal anti-inflammatory agents
Item
known hypersensitivity to nsaids.
boolean
C0746949 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial